AVANT BIO (Fund II) Invests in Nomic Bio, PathPresenter and PL BioScience
September 28, 2024
Growth equity firm AVANT BIO (Avant Bio Fund II LP) participated in three financing rounds: it joined Nomic Bio’s oversubscribed Series B, led PathPresenter’s $7.5M Series A, and joined PL BioScience’s €7.8M Series A. The investments support commercialization, scale-up of production and adoption of life‑science and healthtech solutions across proteomics, digital pathology, and xeno‑free cell culture media.
- Buyers
- AVANT BIO, Avant Bio Fund II LP
- Targets
- Nomic Bio, PathPresenter, PL BioScience GmbH
- Industry
- Biotechnology
- Location
- Multiple (Canada; United States; Germany)
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
AVS Bio Acquires Biorbyt Ltd.
September 23, 2026
Biotechnology
AVS Bio, a portfolio company of Arlington Capital Partners, acquired Biorbyt Ltd., a supplier of life-science research reagents and biomaterials. The acquisition expands AVS Bio’s product catalog, global distribution capabilities, and ecommerce offering; Biorbyt will continue operating under its existing leadership as part of the AVS Bio platform.
-
Court Square and Pamlico Capital Invest in AVANT
December 17, 2025
IT Services
AVANT, a Chicago-based technology services distributor and sales-enablement platform for Trusted Advisors, received a strategic growth investment from Court Square Capital Partners with a reinvestment from existing partner Pamlico Capital. The founders and executive leadership retain significant ownership and will continue to run the business as the new capital will be used to scale AVANT's platform, capabilities, and support continued growth initiatives.
-
IK Partners Acquires Majority Stake in BIOBank
May 29, 2024
Medical Devices
IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.
-
Ampersand Capital Partners Invests in iuvo BioScience
September 28, 2022
Healthcare Services
Ampersand Capital Partners has agreed to acquire a stake in iuvo BioScience, a Rochester-based specialty CRO that provides laboratory, preclinical, clinical development, and scientific consulting services. The investment will fund expansion of iuvo's integrated service portfolio and laboratory capacity and support an active inorganic (add-on) growth strategy; founders Ben Burton and Mary Richardson will remain in leadership roles and as shareholders.
-
Pamlico Capital Announces Strategic Growth Investment in AVANT
October 22, 2021
IT Services
Pamlico Capital provided a strategic growth investment in AVANT to accelerate the Chicago-based IT distributor's expansion and scale its platform for IT decision-making. AVANT's founders and management retain significant ownership and will continue to run the business as the company grows hiring and expands capabilities across cloud, security and UCaaS offerings.
-
StageBio Acquires TPL Path Labs
October 21, 2020
Healthcare Services
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.